
Showing 21 - 40 of 142 results
First synchrotron light is a milestone for new instruments at ANSTO’s Australian Synchrotron
NSTO’S major project to introduce eight new beamlines at the Australian Synchrotron has reached a milestone with the delivery of ‘first light’ to the new MEX-1 beamline.
New experts join Australia's nuclear agency: Focus on innovation, users delivering more benefits to Australians
ANSTO’s Australian Synchrotron launches the Monash Precinct Network in Melbourne
ANSTO has warmly welcomed the official launch of the Monash Precinct Network by Victorian Member for Ashwood, Matt Fregon MP at a special event at the Australian Synchrotron.
Anti leukaemia drug recognised with PM Prize for Innovation
The Australian Synchrotron has played a crucial role in the discovery of a new cancer drug for the treatment of leukaemia.
Acute Myeloid Leukemia
New therapy targets aggressive form of leukaemia
Helping in the fight against COVID-19
Experts at ANSTO’s Australian Synchrotron are prioritising work that could hold the key to fast-tracking the development of a vaccine for COVID-19.
Aussie scientists to develop $500 million-dollar project in Mexico
Two Australian scientists have been appointed to assist with the development of a $500 million-dollar synchrotron facility in Mexico, the first and largest project of its kind.
Celebrating NAIDOC week
ANSTO proudly contributes to measures that recognise all aspects of Aboriginal and Torres Strait Islander culture and heritage during NAIDOC Week and all year.

Removal of dangerous contaminants from dirty water
A group from Monash university has sought to make a new innovative nano-porous sieve material which has the potential to be produced on a global scale and is effective for a much longer time.
Novel idea of recycling CO2 in mining earns scientist win in Falling Walls Lab
Dr Jessica Hamilton, a beamline scientist at the Australian Synchrotron, has won the Falling Walls Lab competition hosted by the Australian Academy of Science for her 3 minute presentation on a novel approach to using mining waste for carbon dioxide capture and a source of carbonate minerals. The event is held to deliver solutions to some of the most promising challenges of our time.

High Performance Macromolecular Crystallography Beamline (MX3)
The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

Sydney Access Proposals
View the upcoming proposal deadlines for access to ANSTO’s Research Portal. The User Office provides support for research proposals and enables you to leverage our world-class research infrastructure and facilities.

Travel Funding
The Australian Synchrotron provides funding support for successful beamtime applicants in the form of travel funding and/or onsite accommodation. Travel funds granted are to be used solely to cover the majority of the cost to travel to the AS facility. The User Office will book accommodation for interstate user groups at the onsite AS Guesthouse.

Publications, posters and conference presentations
Publications, posters and conference presentations for fire impacts reconstructed from a southwest Australian stalagmite.

After your experiment
Following your experiment at the Australian Synchrotron there are certain tasks that users can complete including a user feedback survey and claiming reimbursement for travel expenses.

User Meeting 2020 Invited Speakers
The User Advisory Committee (UAC) are pleased to present this year's invited speakers.
New beamline provides state-of-the-art imaging capability
The new Micro Computed Tomography (MCT) beamline is the first instrument to become operational as part of the $94 million Project BRIGHT program, which will see the completion of eight new beamlines at ANSTO’s Australian Synchrotron.
New antibody-like molecule which could be used in therapy to prevent infection from multiple forms of malaria
The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.